These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16708185)

  • 1. Guillain-Barré syndrome.
    Cosi V; Versino M
    Neurol Sci; 2006 Mar; 27 Suppl 1():S47-51. PubMed ID: 16708185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of mechanical ventilation in Guillain-Barré syndrome.
    Paul BS; Bhatia R; Prasad K; Padma MV; Tripathi M; Singh MB
    Neurol India; 2012; 60(2):150-3. PubMed ID: 22626694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute multiple cranial neuropathy: a variant of Guillain-Barré syndrome?
    Lyu RK; Chen ST
    Muscle Nerve; 2004 Oct; 30(4):433-6. PubMed ID: 15372537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese.
    Hui AC; Chow KM; Tang AS; Fu M; Kay R; Wong KS
    J Clin Neurosci; 2005 Feb; 12(2):134-6. PubMed ID: 15749412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guillain-Barre syndrome. Experience in a third level hospital].
    Téllez-Zenteno JF; Jacinto-Tinajero JC; Avila-Funes A; García-Ramos G; Negrete-Pulido O; Sentíes-Madrid H
    Rev Invest Clin; 2001; 53(4):311-4. PubMed ID: 11599477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome.
    Newswanger DL; Warren CR
    Am Fam Physician; 2004 May; 69(10):2405-10. PubMed ID: 15168961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies in the Guillain-Barré syndrome.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):159-68. PubMed ID: 12894381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.
    Yonekura K; Yokota S; Tanaka S; Kubota H; Fujii N; Matsumoto H; Chiba S
    J Neuroimmunol; 2004 Nov; 156(1-2):204-9. PubMed ID: 15465612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autonomic involvement in Guillain-Barré syndrome].
    Kusunoki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):878-80. PubMed ID: 17432207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apheresis therapy in Guillain-Barré syndrome].
    Nagayama H; Katayama Y
    Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.
    van Doorn PA; Ruts L; Jacobs BC
    Lancet Neurol; 2008 Oct; 7(10):939-50. PubMed ID: 18848313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome--a patient guide and nursing resource.
    Kehoe M
    Axone; 2001 Jun; 22(4):16-24. PubMed ID: 14621501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?].
    Créange A; Sharshar T; Raphaël JC; Gherardi R
    Rev Neurol (Paris); 2002 Jan; 158(1):15-27. PubMed ID: 11938319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.